Sweet Cherry Extract as Permeation Enhancer of Tyrosine Kinase Inhibitors: A Promising Prospective for Future Oral Anticancer Therapies

Although patients would rather oral therapies to injections, the gastrointestinal tract’s low permeability makes this method limiting for most compounds, including anticancer drugs. Due to their low bioavailability, oral antitumor therapies suffer from significant variability in pharmacokinetics and...

Descripción completa

Detalles Bibliográficos
Autores principales: Poggialini, Federica, Vagaggini, Chiara, Brai, Annalaura, Pasqualini, Claudia, Carbone, Anna, Musumeci, Francesca, Schenone, Silvia, Dreassi, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674987/
https://www.ncbi.nlm.nih.gov/pubmed/38004393
http://dx.doi.org/10.3390/ph16111527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674987/
https://www.ncbi.nlm.nih.gov/pubmed/38004393
http://dx.doi.org/10.3390/ph16111527

Ejemplares similares